Metabolic disturbances and wasting in the acquired immunodeficiency syndrome.
about
Decreased Jun-D and myogenin expression in muscle wasting of human cachexiaIKK2 inhibitor alleviates kidney and wasting diseases in a murine model of human AIDSNuclear export of phosphorylated C/EBPbeta mediates the inhibition of albumin expression by TNF-alphaThe anti-cachectic effect of fatty acids.HIV Exploits Antiviral Host Innate GCN2-ATF4 Signaling for Establishing Viral Replication Early in InfectionNF-kappaB activation in hypothalamic pro-opiomelanocortin neurons is essential in illness- and leptin-induced anorexiaCan androgen therapy replete lean body mass and improve muscle function in wasting associated with human immunodeficiency virus infection?Transgenic mice expressing human immunodeficiency virus type 1 in immune cells develop a severe AIDS-like diseaseThe concomitant use of second-generation antipsychotics and long-term antiretroviral therapy may be associated with increased cardiovascular risk.HIV protease inhibitor-related lipodystrophy syndrome.Association between HIV replication and serum leptin levels: an observational study of a cohort of HIV-1-infected South African womenRheumatoid cachexia: cytokine-driven hypermetabolism accompanying reduced body cell mass in chronic inflammation.Reduced tyrosine kinase activity of the insulin receptor in obesity-diabetes. Central role of tumor necrosis factor-alpha.Glucose disorders associated with HIV and its drug therapy.The expression of tumor necrosis factor in human adipose tissue. Regulation by obesity, weight loss, and relationship to lipoprotein lipase.Age-related skeletal muscle decline is similar in HIV-infected and uninfected individuals.Plasma metabolomics identifies lipid abnormalities linked to markers of inflammation, microbial translocation, and hepatic function in HIV patients receiving protease inhibitors.Nuclear magnetic resonance based profiling of biofluids reveals metabolic dysregulation in HIV-infected persons and those on anti-retroviral therapyMolecular-based therapeutic approaches in treatment of anorexia of aging and cancer cachexia.Contribution of metabolic and anthropometric abnormalities to cardiovascular disease risk factorsDisrupted anabolic and catabolic processes may contribute to alcohol-accentuated SAIDS-associated wastingIncreased plasma gln and Leu Ra and inappropriately low muscle protein synthesis rate in AIDS wasting.Chronic alcohol accentuates simian acquired immunodeficiency syndrome-associated wasting.Prospective randomised treatment with recombinant human growth hormone in cystic fibrosisHypothalamic inflammation: a double-edged sword to nutritional diseases.Management of chronic diarrhea in HIV-infected patients: current treatment options, challenges and future directions.Neuropathologies in transgenic mice expressing human immunodeficiency virus type 1 Tat protein under the regulation of the astrocyte-specific glial fibrillary acidic protein promoter and doxycycline.Simian immunodeficiency virus infection of the gastrointestinal tract of rhesus macaques. Functional, pathological, and morphological changes.HIV gp120 inhibits the somatotropic axis: a possible GH-releasing hormone receptor mechanism for the pathogenesis of AIDS wasting.Immunopathogenesis of oropharyngeal candidiasis in human immunodeficiency virus infection.Lipid profiles in young HIV-infected children initiating and changing antiretroviral therapy.Anti-Retroviral Therapy Increases the Prevalence of Dyslipidemia in South African HIV-Infected Patients.Atherosclerotic cardiovascular disease risk in the HAART-treated HIV-1 population.Effects of L-carnitine on serum triglyceride and cytokine levels in rat models of cachexia and septic shock.Lipid Profile of Anti-Retroviral Treatment-Naïve HIV-Infected Patients in Jos, NigeriaContribution of tuberculosis to slim disease in Africa.Differential elevation of circulating interleukin-1 beta, tumor necrosis factor alpha, and interleukin-6 in AIDS-associated cachectic states.The expression of TNF alpha by human muscle. Relationship to insulin resistance.Endotoxin and cytokines induce expression of leptin, the ob gene product, in hamsters.Human chorionic gonadotropin hormone prevents wasting syndrome and death in HIV-1 transgenic mice.
P2860
Q24654557-FAF11267-FD05-4F9C-9EA4-5EB143BFC5F6Q24672467-B7927E92-A5E0-4F4E-9D3B-60E76448CC90Q28365498-396CCA4A-53BE-4E01-A6FB-6C4C0F8C76EBQ33545959-BBE28F94-5183-424B-8973-B5843C955842Q33629133-8E8CD49F-8396-4711-9113-2001F79DDA2EQ33744644-08678706-8840-49C9-8E29-DCF03E4EBAECQ33778748-B74DD7A3-8D4D-45FE-9531-BF8BB1CE3BD2Q33781899-31DC172D-9562-4C7A-8608-46331D7EA8E6Q33849136-7EE33E8C-75C0-4EAA-AC50-C04A96A2227DQ33946902-1D51A004-C1FB-40B1-A9C6-1B47FC2743BCQ34138834-8012157F-3142-447A-9350-B7C4E5252880Q34150320-232DB41E-83F9-4E00-A601-7432D93921BDQ34190131-A9678152-36D8-4956-B85A-2EFF7184E139Q34191314-94137F43-7556-4201-8AA2-6AFCEDFE7327Q34216687-F1770BA7-E550-4E10-B110-5BFA32D7727DQ34584634-8515B0A6-DA1F-43C8-B36A-D2EA439E05CAQ34704820-D5277B8D-956A-49D5-8E23-51161C68710DQ34734134-C082D1F4-462B-409D-9465-EDB26FE851EEQ34764949-BB41AA1E-C1EC-4C4C-82A5-0D023701CDCEQ35206635-8789A396-3DE5-42B9-8429-2ED9B54EB967Q35214147-E8ADFE2C-0379-4798-B9DF-AA5A373239AEQ35224550-D781E9C9-D56D-4757-9316-E3F69B9868DDQ35226613-824F0DB6-D611-41E7-A846-8EE1F375B12DQ35275036-4233FC40-8393-4D02-A186-F3D0A8FD6320Q35318592-975A3CF5-AB5A-4A24-9782-B8AF843A7F69Q35557247-C6156BDE-2592-4A5C-87BF-74A575C32AF4Q35749130-1DA30772-0F23-4BC6-AFE4-10100ACD0BDFQ35833070-F723A20D-9DE5-4B0B-84F8-885E730B1B4AQ35896238-B3BBD0BE-ADF6-47ED-BE8C-8BAF8A0F5727Q35920633-C0714D45-7E87-46E2-A547-C5CDFAE4985BQ35926011-C9B78388-7F2E-4FF0-9358-175BB6F2A2B0Q35960732-B7D9161F-9481-4999-8DAD-97DC34210901Q36070094-6F819FCC-2146-435D-98DA-2AA863925E85Q36081404-121B42C3-4975-4DBD-9613-55BC4A945016Q36789642-8651D7AC-CA9F-4AF7-97B2-93DADEFF6BF0Q36886103-9AEF9FB9-CF81-4858-BA69-49AC2B563BFCQ36927535-80DB4A6B-A56E-4526-A528-5353CBABE6A1Q37352139-B5BC37AD-38C3-4B95-8F7B-7A99B399A344Q37354703-8692578F-DA12-4DBD-AA19-CDF641EE87DFQ37365448-8C4F37B9-E596-405B-B7CE-442F1D1362FB
P2860
Metabolic disturbances and wasting in the acquired immunodeficiency syndrome.
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年学术文章
@wuu
1992年学术文章
@zh-cn
1992年学术文章
@zh-hans
1992年学术文章
@zh-my
1992年学术文章
@zh-sg
1992年學術文章
@yue
1992年學術文章
@zh
1992年學術文章
@zh-hant
name
Metabolic disturbances and wasting in the acquired immunodeficiency syndrome.
@ast
Metabolic disturbances and wasting in the acquired immunodeficiency syndrome.
@en
type
label
Metabolic disturbances and wasting in the acquired immunodeficiency syndrome.
@ast
Metabolic disturbances and wasting in the acquired immunodeficiency syndrome.
@en
prefLabel
Metabolic disturbances and wasting in the acquired immunodeficiency syndrome.
@ast
Metabolic disturbances and wasting in the acquired immunodeficiency syndrome.
@en
P1476
Metabolic disturbances and wasting in the acquired immunodeficiency syndrome.
@en
P2093
Feingold KR
Grunfeld C
P304
P356
10.1056/NEJM199207303270506
P407
P577
1992-07-01T00:00:00Z